Last reviewed · How we verify
NCT04008459: WiSPA
Walking and Balance Related to Sagittal Spinal Posture Alignment
trial testing Therapeutic exercise class in Hyperkyphosis in 41 participants. Terminated before completion.
12 July 2020
Quick facts
| Lead sponsor | University of Oxford |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 41 |
| Start date | 6 April 2019 |
| Primary completion | 12 July 2020 |
| Estimated completion | 18 August 2020 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Therapeutic exercise class
Conditions studied
- Hyperkyphosis — all drugs for Hyperkyphosis →
- Walking, Difficulty — all drugs for Walking, Difficulty →
- Balance; Distorted — all drugs for Balance; Distorted →
- Spinal Disease — all drugs for Spinal Disease →
Sponsor
University of Oxford
Who can join
Eligibility, any sex, with Hyperkyphosis or Walking, Difficulty. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to improve understanding of the relationship between spinal alignment and walking and balance in people who have degenerative spinal conditions.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04008459
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hyperkyphosis
Currently open trials in the same condition.
- NCT06846697 — Effects of Hatha Yoga and Reformer Pilates on Hyperkyphosis · NA · recruiting
- NCT07068360 — Development and Validation of MPF to Prevent and Mitigate Postural Hyperkyphosis in Postmenopausal Women · NA · active not recruiting
- NCT06842758 — Relationship Between Thoracic Hyperkyphosis and Fall Risk in Women with Fragility Vertebral Fractures · active not recruiting
Other University of Oxford trials
Trials by the same sponsor.
- NCT05380388 — A Safety, Immunogenicity and Efficacy Study of PvRII/Matrix-M in Healthy Thai Adults Living in Thailand ( MIST3 ) · Phase 2 · not yet recruiting
- NCT07470424 — A Clinical Study of Piperaquine, Pyronaridine, and Artesunate Administered in Combination in Healthy Adults · Phase 1 · not yet recruiting
- NCT07345910 — Environment, Pathogens, and Host Interactions in Melioidosis · not yet recruiting
- NCT07434973 — Stratification and Treatment in Early Psychosis Study - PROMOTE · Phase 3 · not yet recruiting
- NCT07460401 — 'Do Patient Characteristics Associate With Poor Outcome With Femoral Acetabular Impingement Syndrome (FAIS) Following Ph · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04008459 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Oxford
- Last refreshed: 14 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04008459.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing